miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway

被引:32
作者
Bu, Wenjin [1 ,2 ]
Luo, Tianyou [3 ]
机构
[1] Chongqing Med Univ, Chongqing, Peoples R China
[2] Inner Mongolia Peoples Hosp, Dept Ultrason Med, Hohhot, Peoples R China
[3] Chongqing Med Univ, Dept Radiol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China
关键词
miR-1297; PTEN; Skp2; NSCLC; DOWN-REGULATION; PTEN; APOPTOSIS; GROWTH; SKP2; CHEMORESISTANCE; METASTASIS; EXPRESSION;
D O I
10.1089/dna.2017.3886
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a lipid and protein phosphatase and possesses an antitumor effect in lung cancers. miRNAs are reportedly abnormally expressed in human lung cancers. However, whether miRNA contributes to PTEN expression in non-small cell lung cancers (NSCLCs) has not been clearly clarified. In the present study, we found that miR-1297 probably binds with 3UTR sequence of PTEN and negatively regulated the levels of PTEN in NSCLC cells. First, the expression levels of PTEN and Skp2 were detected by western blotting in NSCLC specimens and paired normal tissue specimens. The results showed that decreased levels of PTEN were detected in NSCLC tissues, compared with paired control tissues (**p<0.01). The expression levels of PTEN were conversely correlated with the levels of Skp2 in clinical NSCLC specimens and NSCLC cell line. Transfection with miR-1297 mimic significantly promoted cell viability of A549 cells and NCI-H460 cells by downregulating the level of PTEN and upregulating the expression of Skp2. Interestingly, knockdown of Skp2 did not affect the expression of PTEN in A549 cells. Thus, miR-1297 might work as an oncogene by regulating PTEN/Akt/Skp2 signaling pathway in NSCLC cells. PTEN and Skp2 might be the potential targets in the clinical therapy of lung cancers.
引用
收藏
页码:976 / 982
页数:7
相关论文
共 24 条
[1]   PTEN Is a Potent Suppressor of Small Cell Lung Cancer [J].
Cui, Min ;
Augert, Arnaud ;
Rongione, Michael ;
Conkrite, Karina ;
Parazzoli, Susan ;
Nikitin, Alexander Yu ;
Ingolia, Nicholas ;
MacPherson, David .
MOLECULAR CANCER RESEARCH, 2014, 12 (05) :654-659
[2]   The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer [J].
Deben, Christophe ;
Wouters, An ;
Op de Beeck, Ken ;
van den Bossche, Jolien ;
Jacobs, Julie ;
Zwaenepoel, Karen ;
Peeters, Marc ;
Van Meerbeeck, Jan ;
Lardon, Filip ;
Rolfo, Christian ;
Deschoolmeester, Vanessa ;
Pauwels, Patrick .
ONCOTARGET, 2015, 6 (26) :22666-22679
[3]   Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway [J].
Fu, Qiao-Fen ;
Liu, Yan ;
Fan, Yue ;
Hua, Sheng-Ni ;
Qu, Hong-Ying ;
Dong, Su-Wei ;
Li, Rui-Lei ;
Zhao, Meng-Yang ;
Zhen, Yan ;
Yu, Xiao-Li ;
Chen, Yi-Yu ;
Luo, Rong-Cheng ;
Li, Rong ;
Li, Li-Bo ;
Deng, Xiao-Jie ;
Fang, Wei-Yi ;
Liu, Zhen ;
Song, Xin .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
[4]  
Gao Jian-Kun, 2015, Asian Pac J Cancer Prev, V16, P3805
[5]   Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells [J].
Hung, Wen-Chun ;
Tseng, Wei-Lung ;
Shiea, Jentaie ;
Chang, Hui-Chiu .
CANCER LETTERS, 2010, 288 (02) :156-161
[6]   Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells [J].
Iskandarani, Ahmad ;
Bhat, Ajaz A. ;
Siveen, Kodappully S. ;
Prabhu, Kirti S. ;
Kuttikrishnan, Shilpa ;
Khan, Muzammil A. ;
Krishnankutty, Roopesh ;
Kulinski, Michal ;
Nasr, Rihab R. ;
Mohammad, Ramzi M. ;
Uddin, Shahab .
JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
[7]   SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation [J].
Li, Ziming ;
Huang, Jia ;
Yuan, Hong ;
Chen, Zhiwei ;
Luo, Qingquan ;
Lu, Shun .
ONCOTARGET, 2016, 7 (14) :18927-18939
[8]   RETRACTED: Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN (Retracted article. See vol. 53, pg. 1743, 2021) [J].
Liang, Naixin ;
Zhou, Xiaoyun ;
Zhao, Ming ;
Zhao, Dachun ;
Zhu, Zhaohui ;
Li, Shanqing ;
Yang, Huaxia .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2015, 47 (07) :530-538
[9]  
Lim WT, 2007, ONCOL REP, V17, P853
[10]   MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN [J].
Liu, Boning ;
Wu, Xiang ;
Liu, Bin ;
Wang, Changli ;
Liu, Yunde ;
Zhou, Qinghua ;
Xu, Ke .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (11) :1692-1704